Blog Posts
Explore timely perspectives from WCG’s clinical trial operations and scientific leaders.
WCG Clinical | Insights
Can you use patient Electronic Health Records to identify and recruit subjects?
Blog Posts
WCG Clinical | Insights
Using an IRB’s Site Relationships to Relieve “Site Crunch” and Reduce Trial Pressures
Blog Posts
WCG Clinical | Insights
Is informed consent needed for post-market patient registry?
Blog Posts
WCG Clinical | Insights
The Top Five Things You Need to Know About Hosting Virtual Investigator Training
Blog Posts
WCG Clinical | Insights
Key Takeaways From FDA’s New Draft Guidance, “Studying Multiple Versions of a Cellular or Gene Therapy Product in an Early-Phase Clinical Trial”
Blog Posts
WCG Clinical | Insights
Does the IRB need to approve doctor-to-doctor letters?
Blog Posts
WCG Clinical | Insights
What are the IRB review requirements for human factors/usability testing?
Blog Posts
WCG Clinical | Insights
Five Tips for Improving Your Site’s Study Start-Up Timelines
Blog Posts
WCG Clinical | Insights
Choosing Between Provisioned, BYOD, and Hybrid Models for ePRO: Which Is Right for Your Clinical Trial?
Blog Posts
WCG Clinical | Insights